-
Je něco špatně v tomto záznamu ?
Low prevalence of neural autoantibodies in perioperative cerebrospinal fluid samples of epilepsy surgery patients: A multicenter prospective study
H. Mojžišová, M. Elišák, D. Krýsl, J. Hanzalová, A. Kalina, M. Petržalka, I. Doležalová, M. Červenka, B. Cvičková, R. Leško, J. Šroubek, D. Sochůrková, J. Hemza, E. Brichtová, J. Dargvainiene, Z. Vojtěch, M. Brázdil, KP. Wandinger, F. Leypoldt, P. Marusič
Jazyk angličtina Země Spojené státy americké
Typ dokumentu multicentrická studie, časopisecké články
Grantová podpora
NU22-04-00366
Ministerstvo Zdravotnictví Ceské Republiky
LX22NPO5107
Ministerstvo Školství, Mládeže a Tělovýchovy
746120
Grantová Agentura, Univerzita Karlova
PubMed
38279908
DOI
10.1111/epi.17894
Knihovny.cz E-zdroje
- MeSH
- autoprotilátky MeSH
- epilepsie * epidemiologie chirurgie komplikace MeSH
- lidé MeSH
- magnetická rezonanční tomografie MeSH
- malformace mozkové kůry * komplikace MeSH
- prevalence MeSH
- prospektivní studie MeSH
- refrakterní epilepsie * diagnostické zobrazování chirurgie komplikace MeSH
- retrospektivní studie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
OBJECTIVE: Refractory epilepsy may have an underlying autoimmune etiology. Our aim was to assess the prevalence of neural autoantibodies in a multicenter national prospective cohort of patients with drug-resistant epilepsy undergoing epilepsy surgery utilizing comprehensive clinical, serologic, and histopathological analyses. METHODS: We prospectively recruited patients undergoing epilepsy surgery for refractory focal epilepsy not caused by a brain tumor from epilepsy surgery centers in the Czech Republic. Perioperatively, we collected cerebrospinal fluid (CSF) and/or serum samples and performed comprehensive commercial and in-house assays for neural autoantibodies. Clinical data were obtained from the patients' medical records, and histopathological analysis of resected brain tissue was performed. RESULTS: Seventy-six patients were included, mostly magnetic resonance imaging (MRI)-lesional cases (74%). Mean time from diagnosis to surgery was 21 ± 13 years. Only one patient (1.3%) had antibodies in the CSF and serum (antibodies against glutamic acid decarboxylase 65) in relevant titers; histology revealed focal cortical dysplasia (FCD) III (FCD associated with hippocampal sclerosis [HS]). Five patients' samples displayed CSF-restricted oligoclonal bands (OCBs; 6.6%): three cases with FCD (one with FCD II and two with FCD I), one with HS, and one with negative histology. Importantly, eight patients (one of them with CSF-restricted OCBs) had findings on antibody testing in individual serum and/or CSF tests that could not be confirmed by complementary tests and were thus classified as nonspecific, yet could have been considered specific without confirmatory testing. Of these, two had FCD, two gliosis, and four HS. No inflammatory changes or lymphocyte cuffing was observed histopathologically in any of the 76 patients. SIGNIFICANCE: Neural autoantibodies are a rare finding in perioperatively collected serum and CSF of our cohort of mostly MRI-lesional epilepsy surgery patients. Confirmatory testing is essential to avoid overinterpretation of autoantibody-positive findings.
Department of Neurology University Hospital Schleswig Holstein Kiel Germany
Department of Neurosurgery Na Homolce Hospital Prague Czech Republic
Department of Neurosurgery St Anne's University Hospital Brno Czech Republic
Institute of Clinical Chemistry University Hospital Schleswig Holstein Kiel Germany
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24006898
- 003
- CZ-PrNML
- 005
- 20240423155548.0
- 007
- ta
- 008
- 240412s2024 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/epi.17894 $2 doi
- 035 __
- $a (PubMed)38279908
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Mojžišová, Hana $u Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic $1 https://orcid.org/0000000283132687
- 245 10
- $a Low prevalence of neural autoantibodies in perioperative cerebrospinal fluid samples of epilepsy surgery patients: A multicenter prospective study / $c H. Mojžišová, M. Elišák, D. Krýsl, J. Hanzalová, A. Kalina, M. Petržalka, I. Doležalová, M. Červenka, B. Cvičková, R. Leško, J. Šroubek, D. Sochůrková, J. Hemza, E. Brichtová, J. Dargvainiene, Z. Vojtěch, M. Brázdil, KP. Wandinger, F. Leypoldt, P. Marusič
- 520 9_
- $a OBJECTIVE: Refractory epilepsy may have an underlying autoimmune etiology. Our aim was to assess the prevalence of neural autoantibodies in a multicenter national prospective cohort of patients with drug-resistant epilepsy undergoing epilepsy surgery utilizing comprehensive clinical, serologic, and histopathological analyses. METHODS: We prospectively recruited patients undergoing epilepsy surgery for refractory focal epilepsy not caused by a brain tumor from epilepsy surgery centers in the Czech Republic. Perioperatively, we collected cerebrospinal fluid (CSF) and/or serum samples and performed comprehensive commercial and in-house assays for neural autoantibodies. Clinical data were obtained from the patients' medical records, and histopathological analysis of resected brain tissue was performed. RESULTS: Seventy-six patients were included, mostly magnetic resonance imaging (MRI)-lesional cases (74%). Mean time from diagnosis to surgery was 21 ± 13 years. Only one patient (1.3%) had antibodies in the CSF and serum (antibodies against glutamic acid decarboxylase 65) in relevant titers; histology revealed focal cortical dysplasia (FCD) III (FCD associated with hippocampal sclerosis [HS]). Five patients' samples displayed CSF-restricted oligoclonal bands (OCBs; 6.6%): three cases with FCD (one with FCD II and two with FCD I), one with HS, and one with negative histology. Importantly, eight patients (one of them with CSF-restricted OCBs) had findings on antibody testing in individual serum and/or CSF tests that could not be confirmed by complementary tests and were thus classified as nonspecific, yet could have been considered specific without confirmatory testing. Of these, two had FCD, two gliosis, and four HS. No inflammatory changes or lymphocyte cuffing was observed histopathologically in any of the 76 patients. SIGNIFICANCE: Neural autoantibodies are a rare finding in perioperatively collected serum and CSF of our cohort of mostly MRI-lesional epilepsy surgery patients. Confirmatory testing is essential to avoid overinterpretation of autoantibody-positive findings.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a autoprotilátky $7 D001323
- 650 _2
- $a prevalence $7 D015995
- 650 12
- $a epilepsie $x epidemiologie $x chirurgie $x komplikace $7 D004827
- 650 12
- $a refrakterní epilepsie $x diagnostické zobrazování $x chirurgie $x komplikace $7 D000069279
- 650 _2
- $a magnetická rezonanční tomografie $7 D008279
- 650 12
- $a malformace mozkové kůry $x komplikace $7 D054220
- 650 _2
- $a retrospektivní studie $7 D012189
- 655 _2
- $a multicentrická studie $7 D016448
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Elišák, Martin $u Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Krýsl, David $u Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Hanzalová, Jitka $u Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic $u Department of Immunology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Kalina, Adam $u Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Petržalka, Marko $u Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Doležalová, Irena $u Brno Epilepsy Center, First Department of Neurology, St. Anne's University Hospital, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Červenka, Matěj $u Na Homolce Hospital Epilepsy Center, Prague, Czech Republic
- 700 1_
- $a Cvičková, Barbora $u Na Homolce Hospital Epilepsy Center, Prague, Czech Republic
- 700 1_
- $a Leško, Robert $u Department of Neurosurgery for Children and Adults, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Šroubek, Jan $u Department of Neurosurgery, Na Homolce Hospital, Prague, Czech Republic $u Department of Neurosurgery, Faculty of Medicine in Hradec Králové, Charles University, Hradec Králové, Czech Republic
- 700 1_
- $a Sochůrková, Daniela $u Department of Neurosurgery, St. Anne's University Hospital, Brno, Czech Republic
- 700 1_
- $a Hemza, Jan $u Department of Neurosurgery, St. Anne's University Hospital, Brno, Czech Republic
- 700 1_
- $a Brichtová, Eva $u Department of Neurosurgery, St. Anne's University Hospital, Brno, Czech Republic
- 700 1_
- $a Dargvainiene, Justina $u Institute of Clinical Chemistry, University Hospital Schleswig-Holstein, Kiel, Germany $u Department of Neurology, University Hospital Schleswig-Holstein, Kiel, Germany
- 700 1_
- $a Vojtěch, Zdeněk $u Na Homolce Hospital Epilepsy Center, Prague, Czech Republic
- 700 1_
- $a Brázdil, Milan $u Brno Epilepsy Center, First Department of Neurology, St. Anne's University Hospital, Faculty of Medicine, Masaryk University, Brno, Czech Republic $1 https://orcid.org/0000000179792343 $7 mzk2004258674
- 700 1_
- $a Wandinger, Klaus-Peter $u Institute of Clinical Chemistry, University Hospital Schleswig-Holstein, Kiel, Germany
- 700 1_
- $a Leypoldt, Frank $u Institute of Clinical Chemistry, University Hospital Schleswig-Holstein, Kiel, Germany $u Department of Neurology, University Hospital Schleswig-Holstein, Kiel, Germany
- 700 1_
- $a Marusič, Petr $u Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
- 773 0_
- $w MED00001567 $t Epilepsia $x 1528-1167 $g Roč. 65, č. 3 (2024), s. 687-697
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38279908 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240412 $b ABA008
- 991 __
- $a 20240423155545 $b ABA008
- 999 __
- $a ok $b bmc $g 2081085 $s 1216665
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 65 $c 3 $d 687-697 $e 20240127 $i 1528-1167 $m Epilepsia $n Epilepsia $x MED00001567
- GRA __
- $a NU22-04-00366 $p Ministerstvo Zdravotnictví Ceské Republiky
- GRA __
- $a LX22NPO5107 $p Ministerstvo Školství, Mládeže a Tělovýchovy
- GRA __
- $a 746120 $p Grantová Agentura, Univerzita Karlova
- LZP __
- $a Pubmed-20240412